Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT)

Transplantation

Volumn 90, Issue 2, 2010, Pages 124-126

  Hoogduijn, Martin J ^a   Popp, Felix C ^b   Grohnert, Anja ^a   Crop, Meindert J ^a   Van Rhijn, Marieke ^a   Rowshani, Ajda T ^a   Eggenhofer, Elke ^b   Renner, Philipp ^b   Reinders, Marlies E ^c   Rabelink, Ton J ^c   Van Der Laan, Luc J W ^a   Dor, Frank J M F ^a   Ijzermans, Jan N M ^a   Genever, Paul G ^d   Lange, Claudia ^e   Durrbach, Antoine ^f   Houtgraaf, Jaco H ^a   Christ, Bruno ^g   Seifert, Martina ^h,i   Shagidulin, Murat ^j   Donckier, Vincent ^k   Deans, Robert ^l   Ringden, Olle ^m   Perico, Norberto ⁿ   Remuzzi, Giuseppe ⁿ   Bartholomew, Amelia ^o   Schlitt, Hans J ^b   Weimar, Willem ^a   Baan, Carla C ^a   Dahlke, Marc H ^b   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF YORK   (United Kingdom)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f UNIVERSITÉ PARIS SACLAY   (France)

^g MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁱ Berlin Brandenburg Center for Regenerative Therapies   (Germany)

^j SHUMAKOV NATIONAL MEDICAL RESEARCH CENTER OF TRANSPLANTOLOGY AND ARTIFICIAL ORGANS   (Russian Federation)

^k FREE UNIVERSITY OF BRUSSELS   (Belgium)

^l ATHERSYS INC   (United States)

^m KAROLINSKA INSTITUTE   (Sweden)

ⁿ MARIO NEGRI INST PHARMACOL RES   (Italy)

^o UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

more..

Author keywords

Clinical trial; Mesenchymal stem cell; MISOT; Solid organ transplantation

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ACUTE GRAFT REJECTION; ALLOGENEIC STEM CELL TRANSPLANTATION; CELL INTERACTION; CELL MATURATION; COMPETITIVE INHIBITION; DENDRITIC CELL; DESENSITIZATION; GRAFT SURVIVAL; HLA SYSTEM; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIA; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REPERFUSION INJURY; SHORT SURVEY; T LYMPHOCYTE; TISSUE REGENERATION; TISSUE REPAIR; TREATMENT PLANNING;

CELL CULTURE TECHNIQUES; GRAFT SURVIVAL; HUMANS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; ORGAN TRANSPLANTATION; SAFETY; T-LYMPHOCYTES; TISSUE THERAPY;

EID: 77954957825     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ea4240     Document Type: Short Survey

References (12)

1. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42.
2. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: Revisiting history, concepts, and assays. Cell Stem Cell 2008; 2: 313.
3. Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 2008; 371: 1579.
4. Ringden O, Uzunel M, Sundberg B, et al. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediasti-num and perforated colon. Leukemia 2007; 21: 2271.
5. Frith JE, Thomson B, Genever P. Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng Part C Methods [Epub ahead of print].
6. Polchert D, Sobinsky J, Douglas G, et al. IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol 2008; 38: 1745.
7. van Poll D, Parekkadan B, Cho CH, et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008; 47: 1634.
8. Imberti B, Morigi M, Tomasoni S, et al. Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol 2007; 18: 2921.
9. Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838.
10. Casiraghi F, Azzollini N, Cassis P, et al. Pretransplant infusion of mes-enchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol 2008; 181: 3933.
11. Popp FC, Eggenhofer E, Renner P, et al. Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate. Transpl Immunol 2008; 20: 55.
12. Dahlke MH, Hoogduijn M, Eggenhofer E, et al. Toward MSC in solid organ transplantation: 2008 position paper of the MISOT study group. Transplantation 2009; 88: 614.